|
Louis Drapeau joined InSite on October 1, 2007. Prior to InSite, he most recently served as Chief Financial Officer, Senior Vice President, Finance, at Nektar Therapeutics where he managed accounting, financial planning, information technology, internal auditing, and investor relations for the biopharmaceutical company headquartered in San Carlos, Calif. Prior to Nektar, he served as Acting Chief Executive Officer from August 2004 to May 2005 and as Senior Vice President and Chief Financial Officer from August 2002 to August 2005 for BioMarin Pharmaceutical Inc. Previously, Drapeau spent 30 years at Arthur Andersen including 19 years as an Audit Partner in Arthur Andersen’s Northern California Audit and Business Consulting practice which included 12 years as Managing Partner.
Drapeau received both his undergraduate degree in engineering and a Masters in Business Administration from Stanford University. He serves as a Director and Member of the Audit Committee of Bio-Rad Laboratories; Director and Member of the Audit Committee of InterMune, Inc.; and Director and Chair of the Audit Committee of Inflazyme Pharmaceuticals Ltd. | 